• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.12% Nasdaq Up 0.71%

    More On HTDS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    • Analyst Opinion
    • Analyst Estimates

    Ownership

    Financials

    Hard to Treat Diseases Inc. (HTDS)

    -Other OTC
    0.00 Down 0.00(99.00%) Apr 24, 2:27PM EDT
    Add to Portfolio
    Prev Close:0.00
    Open:N/A
    Bid:N/A
    Ask:N/A
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:N/A - N/A
    52wk Range:0.00 - 0.00
    Volume:4,200,588
    Avg Vol (3m):47,049
    Market Cap:5.48K
    P/E (ttm):N/A
    EPS (ttm):0.00
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    • No Headlines available for HTDS at this time.

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est () :N/A
    Quarterly EPS Est () :N/A
    Mean Recommendation*:N/A
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Hard to Treat Diseases Inc. is engaged in the export of biological products. The company conducts registrations, carries out clinical trials, and promotes and markets products around the world. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback